Bridgefront Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,876
Closed -$125K 747
2025
Q4
$125K Buy
17,876
+264
+1% +$2.07K 0.03% 484
2025
Q3
$136K Buy
+17,612
New +$137K 0.04% 552
2025
Q1
Sell
-14,306
Closed -$130K 843
2024
Q4
$130K Buy
+14,306
New +$138K 0.04% 533
2023
Q4
Sell
-26,619
Closed -$495K 561
2023
Q3
$495K Buy
26,619
+15,543
+140% +$363K 0.35% 77
2023
Q2
$280K Buy
+11,076
New +$279K 0.15% 272
2021
Q4
Sell
-2,672
Closed -$339K 442
2021
Q3
$339K Buy
+2,672
New +$389K 0.35% 103

Other funds holding TDOC

Bridgefront Capital's TDOC Position: Q1 2026 in Review

Bridgefront Capital sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 17,876 shares — an estimated $125K sold.

Bridgefront Capital first reported a position in TDOC in Q3 2021 and held it in 6 quarters. The position peaked at $495K in Q3 2023. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Bridgefront Capital reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 17,876 Teladoc Health shares in Q1 2026, an estimated $125K.
  • Bridgefront Capital first reported a position in Teladoc Health in Q3 2021 and held it in 6 quarters.
  • Bridgefront Capital's Teladoc Health position peaked at $495K in Q3 2023.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.